Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3699-83-0

Post Buying Request

3699-83-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3699-83-0 Usage

General Description

Phosphonic acid, [2-oxo-2-(phenylamino)ethyl]-, diethyl ester is an organic compound with the chemical formula C12H19NO5P. It is commonly used as a chemical intermediate or building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Phosphonic acid, [2-oxo-2-(phenylamino)ethyl]-, diethyl ester is a diethyl ester of phosphonic acid, and its structure contains a phenylamino group. It is also known by its IUPAC name, diethyl 2-oxo-2-(phenylamino)ethylphosphonate. Phosphonic acid, [2-oxo-2-(phenylamino)ethyl]-, diethyl ester is a colorless to pale yellow liquid and is typically stored and handled under controlled conditions due to its reactivity and potential hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 3699-83-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,6,9 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3699-83:
(6*3)+(5*6)+(4*9)+(3*9)+(2*8)+(1*3)=130
130 % 10 = 0
So 3699-83-0 is a valid CAS Registry Number.

3699-83-0Relevant articles and documents

Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity

O'Boyle, Niamh M.,Barrett, Irene,Greene, Lisa M.,Carr, Miriam,Fayne, Darren,Twamley, Brendan,Knox, Andrew J. S.,Keely, Niall O.,Zisterer, Daniela M.,Meegan, Mary J.

, p. 514 - 534 (2018/02/07)

Estrogen receptor α (ERα) is an important target for the design of drugs such as tamoxifen (2a) and fulvestrant (5). Three series of ER-ligands based on the benzoxepin scaffold structure were synthesized: series I containing an acrylic acid, series II with an acrylamide, and series III with a saturated carboxylic acid substituent. These compounds were shown to be high affinity ligands for the ER with nanomolar IC50 binding values. Series I acrylic acid ligands were generally ERα selective. In particular, compound 13e featuring a phenylpenta-2,4-dienoic acid substituent was shown to be antiproliferative and downregulated ERα and ERβ expression in MCF-7 breast cancer cells. Interestingly, from series III, the phenoxybutyric acid derivative compound 22 was not antiproliferative and selectively downregulated ERβ. A docking study of the benzoxepin ligands was undertaken. Compound 13e is a promising lead for development as a clinically relevant SERD, while compound 22 will be a useful experimental probe for helping to elucidate the role of ERβ in cancer cells.

Microwave-enhanced synthesis of phosphonoacetamides

Gruber, Nadia,Mollo, Mara C.,Zani, Mariana,Orelli, Liliana R.

experimental part, p. 738 - 746 (2011/12/15)

An efficient microwave protocol is described for the Michaelis-Arbuzov synthesis of secondary and tertiary N-aryl (and alkyl) (diethylphosphono) acetamides 1, by reaction of chloro- and bromoacetamides with triethyl phosphite in the presence of catalytic

Plant-growth-regulating N-(phosphonoacetyl)amines

Wieczorrek,Miliszkiewicz,Lejczak,Soroka,Kafarski

, p. 57 - 62 (2007/10/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3699-83-0